Evolent Health (EVH) Bolsters Management Team

Evolent Health, Inc. (NYSE:EVH) is one of the top 10 medical AI companies to buy according to analysts. On July 9, the company strengthened its leadership team with the appointment of Dr. David Lim as chief clinical officer and John Way as CFO of its Performance Suite.

Evolent Health (EVH) Bolsters Management Team

Dr. Lim is tasked with leading Evolent’s 300-person Health team, which focuses on innovation. He joins the team with deep experience, having previously served as the Chief Medical Officer at RightMove Health. He has also served as the Chief Technology Innovation Officer at InnovaCare Health.

Way will oversee the company’s financial aspects, focusing on the at-risk specialty condition management product. He joins Evolent Health with over 20 years of experience in executive financial management.

“I’m excited to welcome Dave and John, not just because of their deep experience but also their commitment to transforming specialty care for patients, payers and providers,” said Seth Bleckley, CEO and Co-Founder of Evolent.

Evolent Health, Inc. (NYSE:EVH) utilizes AI to enhance its healthcare solutions, particularly in areas like utilization management and clinical workflow automation. It has already acquired Machinify’s AI-powered utilization management products to streamline clinical workflows and improve efficiency in specialty condition management.

While we acknowledge the potential of EVH to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than EVH and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Farmland and Agriculture Stocks to Buy According to Billionaires and 10 Best Stocks to Buy Amid Gold Rally.

Disclosure: None. This article is originally published at Insider Monkey.